November 2026
M	T	W	T	F	S	S
	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Michael Wong: Predicting Blood Clots is a Patient Safety Issue

Michael Wong/LinkedIn

Apr 22, 2026, 07:02

Michael Wong: Predicting Blood Clots is a Patient Safety Issue

Michael Wong, Founder and Executive Director at Physician-Patient Alliance for Health and Safety, Board Member of Respiratory Compromise Institute, shared on LinkedIn:

”Predicting Blood Clots is a Patient Safety Issue

A new study highlighted by this MedicalXpress article identifies 23 blood proteins linked to clot risk – 15 of them newly discovered, pointing to something many of us in patient safety have long suspected:

Blood clots aren’t just a ‘clotting’ problem – they’re deeply tied to inflammation, immune response, and broader systemic processes.

Why this matters:

Venous thromboembolism remains a leading cause of preventable harm and death worldwide
Risk today is still often assessed reactively – not predictively
And too many patients are identified after the first event, not before

What’s exciting here is the shift toward predictive, biology-driven risk stratification.

If validated and translated into practice, this kind of proteomic insight could:

Enable earlier identification of high-risk patients
Inform more targeted prevention strategies
Reduce downstream complications like stroke and pulmonary embolism

But it also raises an important question for clinicians, health systems, and patient safety leaders:

Are we ready to integrate this level of precision into routine care – or will implementation lag behind the science?

As we’ve seen in other areas, discovery alone doesn’t improve outcomes.

Adoption, standardization, and education do.

Curious to hear how others are thinking about this – Do these findings meaningfully change how we approach clot prevention today, or is more validation needed before practice shifts?”

Stay updated with Hemostasis Today.